Long-Term Follow-Up of Patients Enrolled in the Early Treatment Diabetic Retinopathy Study (ETDRS)
NCT00001612 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 170
Last updated 2008-03-04
Summary
Patients enrolled in the original Early Treatment Diabetic Retinopathy Study at the Clinical Center at Johns Hopkins Wilmer Eye Institute will be invited for a follow-up visit at the National Eye Institute. Visual function will be assessed with manifest refraction and standardized visual acuity measurement. The progression of retinopathy will be evaluated by ocular exam and fundus photography. A brief medical history will be obtained. The goal of this study is to evaluate the long-term results of patients whose diabetic retinopathy was treated with different strategies of scatter and/or focal laser photocoagulation.
Conditions
Sponsors & Collaborators
-
National Eye Institute (NEI)
lead NIH
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1997-05-31
- Completion
- 2000-08-31
Countries
- United States
Study Locations
More Related Trials
-
Intravitreal Aflibercept Injection in Vision Impairment Due to DME
NCT01331681 ·Status: COMPLETED ·Phase: PHASE3
-
Automated AI-based System for Early Diagnosis of Diabetic Retinopathy
NCT05324189 ·Status: UNKNOWN
-
Blood Factors and Diabetic Retinopathy
NCT00005761 ·Status: COMPLETED
-
Diabetic Retinopathy Assessed by Ultra-wide
NCT03157206 ·Status: UNKNOWN
-
Phase 1 Study of VEGF Trap in Patients With Diabetic Macular Edema
NCT00320814 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Different Fluence Settings for Yellow Subthreshold Laser Treatment in Diabetic Macular Edema
NCT03571659 ·Status: COMPLETED
-
Longitudinal Natural History Study of Retinal Function in Eyes of Patients With Diabetes
NCT07270133 ·Status: NOT_YET_RECRUITING
-
An Investigator-Initiated Study to Assess the Association of Diabetic Retinopathy Severity Scale (DRSS) With Level of Decreased Corneal Sensitivity
NCT05566717 ·Status: UNKNOWN
-
Prevalence of DRP and DME Among Type 1 Diabetics Treated With Long-term Intensified Insulin Therapy
NCT03437551 ·Status: COMPLETED
-
Study of EYP-1901 in Patients With Nonproliferative Diabetic Retinopathy (NPDR)
NCT05383209 ·Status: COMPLETED ·Phase: PHASE2
-
ACCESS: AI for pediatriC diabetiC Eye examS Study
NCT05131451 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Aflibercept in Proliferative Diabetic Retinopathy.
NCT02151695 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Diabetic Macular Edema (DME) With Anti-VEGF and Focal Laser
NCT03590444 ·Status: COMPLETED ·Phase: PHASE4
-
Identifying Patients With Unrecognized Treatable Diabetic Macular Edema
NCT01934920 ·Status: UNKNOWN
-
Observational Study to Assess Genotypes/Phenotypes Correlations in Type-2 Diabetic Retinopathy
NCT01228981 ·Status: COMPLETED
-
Extension Study of Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy
NCT00248131 ·Status: TERMINATED ·Phase: PHASE3
-
A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema
NCT03397264 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Multi-center Study to Evaluate Performance of an Automated Device for the Detection of Diabetic Retinopathy
NCT02963441 ·Status: COMPLETED
-
Assessment of EyeArt Performance With Retinal Imaging Devices
NCT04302012 ·Status: COMPLETED
-
Computer Detection of Diabetic Retinopathy Compared to Clinical Examination
NCT01625598 ·Status: COMPLETED
-
Anti-VEGF Treatment for Prevention of PDR/DME
NCT02634333 ·Status: COMPLETED ·Phase: PHASE3
-
Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR
NCT06790784 ·Status: RECRUITING ·Phase: PHASE3
-
Combination of Standard Lucentis Therapy With Micropulse Diode Laser for the Treatment of Diabetic Macular Edema
NCT02059772 ·Status: UNKNOWN ·Phase: PHASE4
-
Prevalence of DRP and DME Among Type 1 Diabetics Treated With Long-term Intensified Insulin Therapy
NCT02307110 ·Status: COMPLETED ·Phase: NA
-
Pilot Assessment of EyeArt as an Automated Diabetic Retinopathy Screening Tool
NCT03078231 ·Status: COMPLETED